構造データ | PDB-6c5m: Structure of glycolipid aGSA[8,9] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 2.45 Å PDB-6c69: Structure of glycolipid aGSA[12,6P] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 1.937 Å PDB-6c6a: Structure of glycolipid aGSA[16,6P] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 2.45 Å PDB-6c6c: Structure of glycolipid aGSA[20,6P] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 2.08 Å PDB-6c6e: Structure of glycolipid aGSA[26,6P] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 2.18 Å PDB-6c6h: Structure of glycolipid aGSA[8,P5m] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-6c6j: Structure of glycolipid aGSA[8,P5p] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 1.79 Å PDB-6cw6: Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.85 Å PDB-6cw9: Structure of alpha-GC[8,16P] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-6cwb: Structure of alpha-GSA[8,4P] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.85 Å PDB-6cx5: Structure of alpha-GSA[8,8P] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-6cx7: Structure of alpha-GSA[12,6P] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.6 Å PDB-6cx9: Structure of alpha-GSA[16,6P] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.36 Å PDB-6cxa: Structure of alpha-GSA[20,6P] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.65 Å PDB-6cxe: Structure of alpha-GSA[26,6P] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.05 Å PDB-6cxf: Structure of alpha-GSA[26,P5p] bound by CD1d and in complex with the Va14Vb8.2 TCR 手法: X-RAY DIFFRACTION / 解像度: 2.5 Å PDB-6ojp: Structure of glycolipid alpha-GSA[8,6P] in complex with mouse CD1d 手法: X-RAY DIFFRACTION / 解像度: 2.17 Å |
---|
化合物 | ChemComp-J81: (5R,6S,7S)-5,6-dihydroxy-N-nonyl-7-(octanoylamino)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name)
ChemComp-ELM: N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetra
ChemComp-EL7: N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]heptadecanamide (non-preferred name)
ChemComp-EMG: N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]icosanamide
ChemComp-EM4: N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]hexacosanamide
ChemComp-ELG: (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(3-pentylphenyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)te
ChemComp-J76: (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(4-pentylphenyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)te
ChemComp-7LM: N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxy-16-phenylhexadecan-2-yl]octanamide
ChemComp-FJJ: (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-[(1E)-4-phenylbutylidene]-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name)
ChemComp-FJM: (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(8-phenyloctyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name)
ChemComp-ELS: N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(4-pentylphenyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetr
ChemComp-7LP: (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(6-phenylhexyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide
|
---|